Endurant Capital Management LP Stryker Corp Transaction History

Endurant Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$152.46 - $198.0 $1.12 Million - $1.45 Million	-7,319 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$145.0 - $178.65 $2.83 Million - $3.48 Million	-19,502 Reduced 72.71%	7,319 $1.15 Million
Q3 2018 Nov 14, 2018	BUY	$163.25 - $177.68 $2.85 Million - $3.1 Million	17,461 Added 186.55%	26,821 $4.77 Million
Q2 2018 Aug 14, 2018	BUY	$155.17 - $179.78 $1.45 Million - $1.68 Million	9,360 New	9,360 $1.58 Million
Q1 2018 May 15, 2018	SELL	$148.01 - $168.91 $2.64 Million - $3.02 Million	-17,867 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$143.51 - $159.74 $1.04 Million - $1.16 Million	-7,237 Reduced 28.83%	17,867 $2.77 Million
Q3 2017 Nov 14, 2017	BUY	$138.36 - $147.87 $3.47 Million - $3.71 Million	25,104	25,104 $3.57 Million

2,227

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $147B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.